C4 Therapeutics Names Broad Institute’s Phillips CSO

Xconomy Boston — 

Cambridge, MA-based C4 Therapeutics has named Andrew Phillips its chief scientific officer. Phillips was most recently an executive at the Broad Institute of MIT and Harvard, where he headed development of therapeutics. He was a chemistry professor at Yale University before that.